| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Dan Michael Falk is Director at INVZ and has filed Form 4s across 2 companies. Dan Michael Falk's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $148K at current prices.
The biggest single holding is INVZ (~$74K) as Director.
Dan Michael Falk has 3 Form 4 filings on record from May 2026 to September 2026, across 3 companies: Director at Evogene (EVGN), 2026; Director at Nice (NICE), 2026; Director at Innoviz Technologies (INVZ), 2026.
The 3 reported transactions were 1 option or other derivative award, 1 option exercise and 1 stock award.
There are no priced open-market purchases or sales on record, so none of these filings shows a decision to buy or sell shares in the market.
No transactions found
Try adjusting your filters or search criteria